Endophthalmitis after injections of anti-vascular endothelial growth factor drugs.
Michael Wesley
MW
Stewart
D020533:Angiogenesis Inhibitors / Q000009:adverse effects*; D009877:Endophthalmitis / Q000209:etiology* / Q000517:prevention & control; D015818:Eye Infections, Bacterial / Q000209:etiology* / Q000517:prevention & control; D006801:Humans; D058449:Intravitreal Injections; D008397:Masks / Q000706:statistics & numerical data; D012134:Respiratory Protective Devices; D012307:Risk Factors; D013290:Streptococcal Infections / Q000209:etiology* / Q000517:prevention & control; D042461:Vascular Endothelial Growth Factor A / Q000037:antagonists & inhibitors*
D020533:Angiogenesis Inhibitors; C467484:VEGFA protein, human; D042461:Vascular Endothelial Growth Factor A